Unternehmensnachrichten
Matt Sample Discusses Upcoming DSCSA Developments with Drug Topics
Drug Topics
Matt Sample, SVP, manufacturer and replenishment operations at Cencora, was a recent guest on Drug Topics’ Over the Counter Podcast, where he discussed the most notable DSCSA developments coming in 2026, including what small, independent pharmacies need to know as their exemption period ends later this year. He also spoke about how the industry is preparing for a “Y2K” moment with 12-digit NDCs.
- Read about the most notable DSCSA developments coming in 2026: Navigating the DSCSA Road Throughout 2026
- Learn more about barcode failures, non-compliance and 12-digit NDCs: Q&A: Pharmacies Should Use VRS Tools, Document DSCSA Compliance Processes
- Listen to the full podcast on DSCSA updates this year and beyond: DSCSA Compliance Updates for Independent Pharmacies in 2026
- Learn more about the next “Y2K” moment in the industry: NDC 12: The 'Y2K' Moment for the Pharmaceutical Industry